Literature DB >> 19332197

Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.

Nathan D Lambert1, Matthew T Sacrinty, Terry R Ketch, Samuel J Turner, Renato M Santos, Kurt R Daniel, Robert J Applegate, Michael A Kutcher, David C Sane.   

Abstract

BACKGROUND: Kidney failure (stage 5 chronic kidney disease [CKD]) is an independent risk factor for stent thrombosis (ST). Moderate (stage 3-4) CKD and proteinuria are both associated with adverse cardiovascular events, including worse outcomes after myocardial infarction (MI). Whether moderate CKD and proteinuria increase the risk of ST after MI is not known. This study evaluated the risk of ST associated with moderate CKD and dipstick proteinuria.
METHODS: We retrospectively analyzed clinical and laboratory data from 956 non-stage 5 CKD patients who were admitted with MI and received intracoronary stenting. Clinical follow-up was collected at 1 year for definite or probable ST, as well as for all-cause mortality, nonfatal MI or death, and target vessel revascularization or coronary artery bypass graft surgery.
RESULTS: After adjustment for multiple clinical and biochemical covariates, patients with both estimated glomerular filtration rate (GFR) of 15 to 59 mL min(-1) 1.73 m(-2) and > or =30 mg/dL dipstick proteinuria had increased cumulative incidence of ST (hazard rate [HR] 3.69, 95% CI 1.54-8.89), all-cause mortality (HR 2.68, 95% CI 1.34-5.37), and nonfatal MI or death (HR 3.20, 95% CI 1.77-5.81) at 1 year. In addition, estimated GFR of 15 to 59 mL min(-1) 1.73 m(-2) was a significant independent predictor of ST (HR 2.61, 95% CI 1.33-5.10). Dipstick proteinuria > or =30 mg/dL was associated with a trend toward increased risk for all outcomes.
CONCLUSIONS: In an acute MI population, moderate CKD was identified as a novel prognostic marker for ST. In addition, patients with both decreased GFR and proteinuria had higher incidences of all-cause mortality and nonfatal MI or death than patients with either condition alone.

Entities:  

Mesh:

Year:  2009        PMID: 19332197     DOI: 10.1016/j.ahj.2009.01.009

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.

Authors:  Omar K Siddiqi; Kyle J Smoot; Alyssa B Dufour; Kelly Cho; Melissa Young; David R Gagnon; Samantha Ly; Sara Temiyasathit; David P Faxon; J Michael Gaziano; Scott Kinlay
Journal:  Heart       Date:  2015-07-24       Impact factor: 5.994

3.  Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.

Authors:  Joshua A Walker; Sean Richards; Stephen A Whelan; Sung Bok Yoo; Teresa L Russell; Nkiruka Arinze; Saran Lotfollahzadeh; Marc A Napoleon; Mostafa Belghasem; Norman Lee; Laura M Dember; Katya Ravid; Vipul C Chitalia
Journal:  J Am Soc Nephrol       Date:  2021-11       Impact factor: 10.121

Review 4.  Thrombosis in the uremic milieu--emerging role of "thrombolome".

Authors:  Moshe Shashar; Jean Francis; Vipul Chitalia
Journal:  Semin Dial       Date:  2014-06-24       Impact factor: 3.455

5.  Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Authors:  Vipul C Chitalia; Sowmya Shivanna; Jordi Martorell; Mercedes Balcells; Irene Bosch; Kumaran Kolandaivelu; Elazer R Edelman
Journal:  Circulation       Date:  2012-12-25       Impact factor: 29.690

6.  Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.

Authors:  Chih-Cheng Wu; Mu-Yang Hsieh; Szu-Chun Hung; Ko-Lin Kuo; Tung-Hu Tsai; Chao-Lun Lai; Jaw-Wen Chen; Shing-Jong Lin; Po-Hsun Huang; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

7.  Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial.

Authors:  Heli M Lahtela; Tuomas O Kiviniemi; Marja K Puurunen; Axel Schlitt; Andrea Rubboli; Antti Ylitalo; José Valencia; Gregory Y H Lip; K E Juhani Airaksinen
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

8.  The Impact of Renal Dysfunction on the Long Term Clinical Outcomes of Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era.

Authors:  Ki Hong Choi; Jeong Hoon Yang; Ji Hwan Kim; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Hyeon-Cheol Gwon; Sang Hoon Lee; Seung-Hyuk Choi
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.